Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Systemic Inflammation, Oxidative Damage to Nucleic Acids, and Metabolic Syndrome in the Pathogenesis of Psoriasis.

Borska L, Kremlacek J, Andrys C, Krejsek J, Hamakova K, Borsky P, Palicka V, Rehacek V, Malkova A, Fiala Z.

Int J Mol Sci. 2017 Oct 25;18(11). pii: E2238. doi: 10.3390/ijms18112238.

2.

Changes in circulating cell-free DNA and nucleosomes in patients with exacerbated psoriasis.

Beranek M, Fiala Z, Kremlacek J, Andrys C, Krejsek J, Hamakova K, Chmelarova M, Palicka V, Borska L.

Arch Dermatol Res. 2017 Dec;309(10):815-821. doi: 10.1007/s00403-017-1785-5. Epub 2017 Oct 13.

PMID:
29027583
3.

Serum Level of Antibodies (IgG, IgM) Against Benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA Adducts in Children Dermatologically Exposed to Coal Tar.

Borský P, Andrýs C, Krejsek J, Hamáková K, Kremláček J, Málková A, Bartošová L, Fiala Z, Palička V, Borská L.

Acta Medica (Hradec Kralove). 2017;60(1):27-31. doi: 10.14712/18059694.2017.46. Epub 2017 May 3.

4.

Droplet Digital PCR Analysis of GSTM1 Deletion Polymorphism in Psoriatic Subjects Treated with Goeckerman Therapy.

Beránek M, Fiala Z, Kremláček J, Andrýs C, Hamáková K, Palička V, Borská L.

Acta Medica (Hradec Kralove). 2016;59(3):75-78. doi: 10.14712/18059694.2016.94. Epub 2016 Aug 29.

5.

Genotoxic changes in peripheral lymphocytes after therapeutic exposure to crude coal tar and ultraviolet radiation.

Malkova A, Kohlerova R, Fiala Z, Hamakova K, Selke-Krulichova I, Borska L.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Dec;160(4):553-558. doi: 10.5507/bp.2016.032. Epub 2016 Jun 9.

6.

Genetic polymorphisms in biotransformation enzymes for benzo[a]pyrene and related levels of benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in Goeckerman therapy.

Beranek M, Fiala Z, Kremlacek J, Andrys C, Hamakova K, Chmelarova M, Palicka V, Borska L.

Toxicol Lett. 2016 Jul 25;255:47-51. doi: 10.1016/j.toxlet.2016.05.009. Epub 2016 May 14.

PMID:
27188524
7.

Influence of dermal exposure to ultraviolet radiation and coal tar (polycyclic aromatic hydrocarbons) on the skin aging process.

Borska L, Andrys C, Krejsek J, Palicka V, Vorisek V, Hamakova K, Kremlacek J, Borsky P, Fiala Z.

J Dermatol Sci. 2016 Mar;81(3):192-202. doi: 10.1016/j.jdermsci.2015.12.010. Epub 2015 Dec 28.

PMID:
26748978
8.

Selected Inflammatory and Metabolic Markers in Psoriatic Patients Treated with Goeckerman Therapy.

Kondelkova K, Borska L, Andrys C, Krejsek J, Hamakova K, Rendarova S, Rehacek V, Kremlacek J, Fiala Z.

Mediators Inflamm. 2015;2015:979526. doi: 10.1155/2015/979526. Epub 2015 Jun 8.

9.

Oxidative damage to nucleic acids and benzo(a)pyrene-7,8-diol-9,10-epoxide-DNA adducts and chromosomal aberration in children with psoriasis repeatedly exposed to crude coal tar ointment and UV radiation.

Borska L, Andrys C, Krejsek J, Palicka V, Chmelarova M, Hamakova K, Kremlacek J, Fiala Z.

Oxid Med Cell Longev. 2014;2014:302528. doi: 10.1155/2014/302528. Epub 2014 Aug 12.

10.

Serum level of antibody against benzo[a]pyrene-7,8-diol-9,10-epoxide-DNA adducts in people dermally exposed to PAHs.

Borska L, Andrys C, Krejsek J, Palicka V, Chmelarova M, Hamakova K, Kremlacek J, Borsky P, Fiala Z.

J Immunol Res. 2014;2014:834389. doi: 10.1155/2014/834389. Epub 2014 Apr 13.

11.

Genotoxic and apoptotic effects of Goeckerman therapy for psoriasis.

Borska L, Andrys C, Krejsek J, Hamakova K, Kremlacek J, Palicka V, Ranna D, Fiala Z.

Int J Dermatol. 2010 Mar;49(3):289-94. doi: 10.1111/j.1365-4632.2009.04258.x.

PMID:
20465666
12.

Urinary mutagenicity and genotoxic risk in children with psoriasis after therapeutic exposure to polycyclic aromatic hydrocarbons and ultraviolet radiation.

Borska L, Smejkalova J, Cerna M, Hamakova K, Kucera I, Kremlacek J, Pelikanova D, Fiala Z.

Mutat Res. 2010 Feb;696(2):144-7. doi: 10.1016/j.mrgentox.2010.01.003. Epub 2010 Jan 21.

PMID:
20096371
13.

Genotoxic hazard and cellular stress in pediatric patients treated for psoriasis with the Goeckerman regimen.

Borska L, Andrys C, Krejsek J, Hamakova K, Kremlacek J, Ettler K, Vellappally S, Vimal J, Fiala Z.

Pediatr Dermatol. 2009 Jan-Feb;26(1):23-7. doi: 10.1111/j.1525-1470.2008.00774.x.

PMID:
19250400
14.

Serum levels of the pro-inflammatory cytokine interleukin-12 and the anti-inflammatory cytokine interleukin-10 in patients with psoriasis treated by the Goeckerman regimen.

Borska L, Andrys C, Krejsek J, Hamakova K, Kremlacek J, Ettler K, Fiala Z.

Int J Dermatol. 2008 Aug;47(8):800-5. doi: 10.1111/j.1365-4632.2008.03677.x.

PMID:
18717859
15.

Immunologic changes in TNF-alpha, sE-selectin, sP-selectin, sICAM-1, and IL-8 in pediatric patients treated for psoriasis with the Goeckerman regimen.

Borska L, Fiala Z, Krejsek J, Andrys C, Vokurkova D, Hamakova K, Kremlacek J, Ettler K.

Pediatr Dermatol. 2007 Nov-Dec;24(6):607-12.

PMID:
18035981
16.

Genotoxic effect of Goeckerman regimen of psoriasis.

Fiala Z, Borska L, Pastorkova A, Kremlacek J, Cerna M, Smejkalova J, Hamakova K.

Arch Dermatol Res. 2006 Oct;298(5):243-51. Epub 2006 Aug 11.

PMID:
16902768
17.

[Genotoxic risk of Goeckerman's therapy of psoriasis. Pilot study--children].

Borská L, Fiala Z, Smejkalová J, Hamáková K, Kremlácek J.

Acta Medica (Hradec Kralove) Suppl. 2004;47(1):19-21. Czech.

PMID:
15745054

Supplemental Content

Loading ...
Support Center